Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 765292, 7 pages
http://dx.doi.org/10.1155/2015/765292
Research Article

Sex Differences in Immunology: More Severe Development of Experimental Pulmonary Hypertension in Male Rats Exposed to Vascular Endothelial Growth Factor Receptor Blockade

1TSI Laboratory, University Heart Center Hamburg, 20246 Hamburg, Germany
2Cardiovascular Research Center Hamburg (CVRC) and DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany
3Cardiovascular Surgery, University Heart Center Hamburg, 20246 Hamburg, Germany
4Thoracic and Vascular Surgery and Heart-Lung Transplantation, Marie Lannelongue Hospital, University of Paris-Sud, 92350 Le Plessis-Robinson, France
5Department of Cardiothoracic Surgery and Stanford Cardiovascular Institute, Stanford University, Stanford, CA 94305, USA

Received 25 May 2015; Accepted 5 August 2015

Academic Editor: Rei Shibata

Copyright © 2015 Julien Guihaire et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Shapiro, G. L. Traiger, M. Turner, M. D. McGoon, P. Wason, and R. J. Barst, “Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management,” Chest, vol. 141, no. 2, pp. 363–373, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Humbert, O. Sitbon, A. Chaouat et al., “Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era,” Circulation, vol. 122, no. 2, pp. 156–163, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. P. Tofovic, “Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease,” Journal of Cardiovascular Pharmacology, vol. 56, no. 6, pp. 696–708, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. P. Tofovic, X. Zhang, E. K. Jackson, S. Dacic, and G. Petrusevska, “2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension,” Vascular Pharmacology, vol. 45, no. 6, pp. 358–367, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. L. B. Sweeney, H. J. Bogaard, R. Natarajan, D. Kraskauskas, and N. F. Voelkel, “Female gender protects against angioproliferative pulmonary hypertension induced by VEGF receptor inhibition and hypoxic exposure,” in Proceedings of the American Thoracic Society International Conference, Abstract A1826, San Diego, Calif, USA, May 2009.
  6. L. Taraseviciene-Stewart, M. R. Nicolls, D. Kraskauskas et al., “Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling,” American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 12, pp. 1280–1289, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Rondelet, F. Kerbaul, S. Motte et al., “Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension,” Circulation, vol. 107, no. 9, pp. 1329–1335, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Paulin and E. D. Michelakis, “The estrogen puzzle in pulmonary arterial hypertension,” Circulation, vol. 126, no. 9, pp. 1016–1019, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. K. M. Mair, A. K. Z. Johansen, A. F. Wright, E. Wallace, and M. R. Maclean, “Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response,” British Journal of Pharmacology, vol. 171, no. 3, pp. 567–579, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. H.-P. Gerber, A. McMurtrey, J. Kowalski et al., “Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway: requirement for Flk-1/KDR activation,” The Journal of Biological Chemistry, vol. 273, no. 46, pp. 30336–30343, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Jacobs, M. C. van de Veerdonk, P. Trip et al., “The right ventricle explains sex differences in survival in idiopathic pulmonary arterial hypertension,” Chest, vol. 145, no. 6, pp. 1230–1236, 2014. View at Publisher · View at Google Scholar · View at Scopus